BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2432405)

  • 1. gp140v-fms molecules expressed at the surface of cells transformed by the McDonough strain of feline sarcoma virus are phosphorylated in tyrosine and serine.
    Tamura T; Simon E; Niemann H; Snoek GT; Bauer H
    Mol Cell Biol; 1986 Dec; 6(12):4745-8. PubMed ID: 2432405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences.
    Wheeler EF; Roussel MF; Hampe A; Walker MH; Fried VA; Look AT; Rettenmier CW; Sherr CJ
    J Virol; 1986 Aug; 59(2):224-33. PubMed ID: 3525854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming mechanism of the feline sarcoma virus encoded v-fms oncogene product.
    Tamura T; Hadwiger-Fangmeier A; Simon E; Smola U; Geschwill H; Schütz B; Trouliaris S; Boscheck B; Niemann H; Bauer H
    Behring Inst Mitt; 1991 Jul; (89):93-9. PubMed ID: 1834054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of a transformation-defective mutant of the McDonough strain of feline sarcoma virus exhibiting tyrosine kinase activity in vitro but not in vivo.
    Tamura T; Hennig D; Grell M; Niemann H; Boschek B
    J Virol; 1988 Jun; 62(6):2150-7. PubMed ID: 2835515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine phosphorylations in vivo associated with v-fms transformation.
    Morrison DK; Browning PJ; White MF; Roberts TM
    Mol Cell Biol; 1988 Jan; 8(1):176-85. PubMed ID: 2447483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of chicken fibroblasts by the v-fms oncogene.
    Tamura T; Hadwiger-Fangmeier A; Boschek B; Niemann H
    Virology; 1990 Oct; 178(2):401-9. PubMed ID: 2171188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate glycosylation of the fms gene product is a prerequisite for its transforming potency.
    Hadwiger A; Niemann H; Käbisch A; Bauer H; Tamura T
    EMBO J; 1986 Apr; 5(4):689-94. PubMed ID: 3086087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessment of the v-fms sequence: threonine phosphorylation of the COOH-terminal domain.
    Smola U; Hennig D; Hadwiger-Fangmeier A; Schütz B; Pfaff E; Niemann H; Tamura T
    J Virol; 1991 Nov; 65(11):6181-7. PubMed ID: 1833563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms).
    Donner L; Fedele LA; Garon CF; Anderson SJ; Sherr CJ
    J Virol; 1982 Feb; 41(2):489-500. PubMed ID: 6281462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor (EGF) modulation of feline sarcoma virus fms tyrosine kinase activity, internalization, degradation, and transforming potential in an EGF receptor/v-fms chimera.
    Riedel H
    J Virol; 1994 Jan; 68(1):411-24. PubMed ID: 8254751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to the transformation-specific glycoprotein encoded by the feline retroviral oncogene v-fms.
    Anderson SJ; Furth M; Wolff L; Ruscetti SK; Sherr CJ
    J Virol; 1982 Nov; 44(2):696-702. PubMed ID: 6292527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fms gene and the CSF-1 receptor.
    Sherr CJ; Rettenmier CW
    Cancer Surv; 1986; 5(2):221-32. PubMed ID: 3022923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinase activity of the v-fms encoded protein has a low pH optimum.
    Lyman SD; Rohrschneider LR
    Oncogene Res; 1989; 4(2):149-55. PubMed ID: 2654815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line.
    Wheeler EF; Rettenmier CW; Look AT; Sherr CJ
    Nature; 1986 Nov 27-Dec 3; 324(6095):377-80. PubMed ID: 3024013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of tyrosine residues Y705 and Y807 on the transforming potency of the v-fms oncogene product of feline sarcoma virus.
    Trouliaris S; Hadwiger-Fangmeier A; Heimann M; Tamura T
    Arch Virol; 1995; 140(1):179-86. PubMed ID: 7646343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of the transforming protein of Rous sarcoma virus: direct demonstration of phosphorylation of serine 17 and identification of an additional site of tyrosine phosphorylation in p60v-src of Prague Rous sarcoma virus.
    Patschinsky T; Hunter T; Sefton BM
    J Virol; 1986 Jul; 59(1):73-81. PubMed ID: 2423705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of functional domains of the v-fms-encoded protein of Susan McDonough strain feline sarcoma virus by linker insertion mutagenesis.
    Lyman SD; Rohrschneider LR
    Mol Cell Biol; 1987 Sep; 7(9):3287-96. PubMed ID: 2823125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms.
    Mancini A; Koch A; Wilms R; Tamura T
    J Biol Chem; 2002 Apr; 277(17):14635-40. PubMed ID: 11847211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the monomeric and complex-associated forms of the gag-onc fusion proteins of three isolates of feline sarcoma virus: phosphorylation, kinase activity, acylation, and kinetics of complex formation.
    Ziemiecki A
    Virology; 1986 Jun; 151(2):265-73. PubMed ID: 2422812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity.
    Kaplan DR; Whitman M; Schaffhausen B; Pallas DC; White M; Cantley L; Roberts TM
    Cell; 1987 Sep; 50(7):1021-9. PubMed ID: 2441878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.